167 Results for "

TC

" in MedChemExpress (MCE) Product Catalog:
Products (167)

167 Results for "TC" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-15513
CAS No.: 315694-89-4
Purity:  96.87%
Target:  

DAPK

Research Areas:  

Cancer

TC-DAPK 6 is a potent, ATP-competitive, and highly selective DAPK inhibitor (IC50=69 and 225 nM against DAPK1 and DAPK3, respectively, with 10 μM ATP).
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-103007
CAS No.: 1621175-65-2
Purity:  99.36%
Synonyms: GPR39-C3
Target:  

GPR39

Research Areas:  

Metabolic Disease Endocrinology

TC-G-1008 (GPR39-C3) is a potent and orally available GPR39 agonist with EC50 values of 0.4 and 0.8 nM for rat and human receptors respectively.
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-19348
CAS No.: 937039-45-7
Synonyms: RGFA-8; TC-H 106; Histone Deacetylase Inhibitor VII
Research Areas:  

Neurological Disease Cancer

Pimelic Diphenylamide 106 (TC-H 106) is a slow, tight binding class I HDAC inhibitor (inhibits HDAC1, 2, and 3 with IC50 values of 150 nM, 760 nM, and 370 nM, respectively), with no activity against class II HDACs. Pimelic Diphenylamide 106 modulates dopamine concentration and protects dopamine cells by inducing VMAT2 expression. Pimelic Diphenylamide 106 can be used in the study of neuropsychiatric diseases such as attention deficit hyperactivity disorder (ADHD) .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-107574
CAS No.: 17328-16-4
Purity:  98.03%
TC-E 5003 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 of 1.5 µM against hPRMT1. TC-E 5003 modulates the lipopolysaccharide (LPS) (HY-D1056)-induced AP-1 and NF-κB signaling pathways with anti-inflammatory properties. TC-E 5003 also upregulates the expression of Ucp1 and Fgf21, activates protein kinase A signaling and lipolysis in primary subcutaneous adipocytes from both mouse and humans. TC-E 5003 is promising for research of obesity and associated metabolic disorders, oxidative stress, inflammation and cancers .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-10319
CAS No.: 867017-68-3
Purity:  98.16%
Synonyms: ROCK-IN-2; Azaindole 1; TC-S 7001
Target:  

ROCK

Research Areas:  

Cardiovascular Disease

BAY-549 (Azaindole 1), a chemical probe, is an orally active and ATP-competitive ROCK inhibitor with IC50s of 0.6 and 1.1 nM for human ROCK-1 and ROCK-2, respectively .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-P1102
CAS No.: 368874-34-4
Target:  

CXCR HIV

Research Areas:  

Infection Cancer

TC14012, a serum-stable derivative of T140, is a selective and peptidomimetic CXCR4 antagonist with an IC50 of 19.3 nM. TC14012 is a potent CXCR7 agonist with an EC50 of 350 nM for recruiting β-arrestin 2 to CXCR7. TC14012 has anti-HIV activity and anti-cancer activity .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-108597
CAS No.: 1082739-92-1
Purity:  99.68%
TC-S 7005 is a Polo-like kinases (Plks) inhibitor with IC50s of 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-107588
CAS No.: 916734-43-5
Purity:  99.94%
Target:  

Integrin

Research Areas:  

Cardiovascular Disease

TC-I 15 (TC-I-15) is a type of allosteric collagen-binding integrin α2β1 inhibitor, and it also inhibits α1β1 and α11β1. TC-I 15 inhibits platelet adhesion to collagen and thrombus deposition. TC-I 15 prevents the formation of a pre-metastatic microenvironment by inhibiting the uptake of cancer-associated fibroblast (CAF) extracellular vesicles (EVs) by lung fibroblasts, which reduces the metastasis of salivary gland adenocystic carcinoma (SACC) to the lungs in mouse models, .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-101524
CAS No.: 2093393-05-4
Purity:  99.04%
Target:  

Mixed Lineage Kinase

Research Areas:  

Cancer

TC13172 is a mixed lineage kinase domain-like protein (MLKL) inhibitor with an EC50 value of 2 nM for HT-29 cells .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-129478
CAS No.: 100823-03-8
Purity:  99.55%
Target:  

Caspase Bcl-2 Family CDK

Research Areas:  

Cancer

TC11 is a MCL1 degrader and Caspase-9 and CDK1 activator. TC11 functions as a phenylacetylamide derivative and is structurally related to immunomodulatory active molecules. TC11 induces degradation of MCL1 leading to apoptotic death during prolonged mitotic arrest.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-110200
CAS No.: 37710-81-9
Purity:  98.51%
Synonyms: m-Phenylenediacrylic acid; m-Benzenediacrylic acid
Target:  

Aquaporin

Research Areas:  

Metabolic Disease Cancer

TC AQP1 1 (m-Phenylenediacrylic acid) is a potent AQP1 inhibitor. TC AQP1 1 inhibits AQP1-mediated water flux in oocytes, with an IC50 of 8 μM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19430
CAS No.: 2070015-24-4
Synonyms: RGFA-8 analog; TC-H 106 analog
Target:  

HDAC

Research Areas:  

Cancer

Pimelic Diphenylamide 106 analog is the analog of Pimelic Diphenylamide 106, with unknown activity.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-B1434
CAS No.: 957-68-6
Synonyms: 7-ACA
7-aminocephalosporanic acid (7-ACA) is a HSP90β inhibitor and an antibiotic. 7-Aminocephalosporanic acid is the core chemical structure of the synthesis of cephalosporin antibiotics and an effective β-lactamase inhibitor .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-18371
CAS No.: 1422955-31-4
Research Areas:  

Inflammation/Immunology

TC-S 7009 is a potent and selective HIF-2α inhibitor with a Kd of 81 nM. TC-S 7009 is more selective for HIF-2α than HIF-1α (Kd ? 5 μM). TC-S 7009 disrupts HIF-2α heterodimerization, decreases DNA-binding activity, and reduces HIF-2α target gene expression .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-107573
CAS No.: 1453071-47-0
Purity:  99.00%
Target:  

Histone Demethylase

Research Areas:  

Cancer

KDM2/7-IN-1 (TC-E 5002) is a selective histone demethylase KDM2/7 subfamily inhibitor (IC50 values are 0.2, 1.2, 6.8, 55, 83, >100 and >120 μM for KDM7A, KDM7B, KDM2A, KDM5A, KDM4C, KDM6A and KDM4A respectively). KDM2/7-IN-1 inhibits growth of HeLa and KYSE-150 cancer cells in vitro .
loading...
    loading...
Cat. No.: HY-124591
CAS No.: 1381769-23-8
Purity:  98.73%
Research Areas:  

Neurological Disease

TC-2153 is a selective inhibitor of striatal-enriched protein tyrosine phosphatase (STEP), with psychotropic activity and low acute toxicity. TC-2153 increases the expression of brain-derived neurotropic factor (BDNF) in the brain. And it decreases MAOA and 5-HT1A receptors mRNA level in midbrain. TC-2153 also inhibits 5-HT2A receptor-mediated signaling .
loading...
    loading...
Cat. No.: HY-107405
CAS No.: 1211866-85-1
Purity:  99.67%
Target:  

Sodium Channel

Research Areas:  

Neurological Disease

TC-N 1752 is a potent and orally active inhibitor of Nav1.7, with IC50s of 0.17 μM, 0.3 μM, 0.4 μM, 1.1 μM and 2.2 μM at hNav1.7, hNav1.3, hNav1.4, hNaV1.5 and rNav1.8, respectively. TC-N 1752 also inhibits tetrodotoxin-sensitive sodium channels. TC-N 1752 shows analgesic efficacy in the Formalin model of pain .
loading...
    loading...
Cat. No.: HY-110173
CAS No.: 1415407-60-1
Purity:  99.83%
TC-G 1005 is a potent, selective and orally active agonist of the BA receptor Takeda G protein-coupled receptor 5 (TGR5), with EC50s of 0.72 and 6.2 nM for hTGR5 and mTGR5, respectively. TC-G 1005 can reduce glucose levels in vivo .
loading...
    loading...
Cat. No.: HY-110199
CAS No.: 1221349-53-6
Purity:  ≥99.0%
Target:  

TRP Channel

Research Areas:  

Neurological Disease

TC-I 2014 (compound 5) is a potent and orally active Benzimidazole-containing transient receptor potential melastatin 8 (TRPM8) antagonist, with IC50 values of 0.8 nM, 3.0 nM and 4.4 nM for canine, human and rat channels respectively. TC-I 2014 exhibits antiallodynic properties in pain models .
loading...
    loading...
Cat. No.: HY-107615
CAS No.: 1393814-38-4
Purity:  99.69%
Target:  

LPL Receptor

Research Areas:  

Cancer

TC LPA5 4 is a LPA5 (GPR92)-specific non-lipid antagonist. TC LPA5 4 inhibits LPA-induced aggregation of isolated human platelet (LPA5-RH7777 cell line) with an IC50 of 800 nM. TC LPA5 4 displays selectivity for LPA5 over 80 other screened agent targets . TC LPA5 4 inhibits cell proliferation and migration of thyroid cancer cells .
loading...
    loading...